Home

Team

Investment Approach

For Entrepreneurs

Portfolio Companies

News & Events

Archive

News & Events

Page

2 3

Xenome Completes A$8.0 million Financing

23 / 12 / 2011

UPTAKE MEDICAL ANNOUNCES TGA APPROVAL OF INTERVAPOR FOR PATIENTS WITH SEVERE EMPHYSEMA

22 / 12 / 2011

Uptake gets Australian approval

22 / 12 / 2011

SUCCESSFUL COMPLETION OF HATCHTECH�??S PHASE 2B CLINICAL TRIAL IN HEAD LICE

20 / 12 / 2011

Media release: Investing in Innovative Companies

09 / 12 / 2011

First patient treated in IDE trial of AeroForm device

09 / 12 / 2011

Thomson Reuters: The ones to watch: A pharma matters report

08 / 12 / 2011

SHC: Easing the squeeze

08 / 12 / 2011

First Patient Treated in IDE Trial of New Post-Mastectomy Expansion Device

06 / 12 / 2011

Emerging Company Profile: Euthymics

05 / 12 / 2011

ASX Announcement: Sunshine Hearts

05 / 12 / 2011

HATCHTECH APPOINTS TIM WAUGH AS CEO

02 / 12 / 2011

EUTHYMICS BIOSCIENCE, INC. PRESENTS DATA

02 / 12 / 2011

SHC Piper Newsletter 2011

23 / 11 / 2011

Uptake Medical: Investor Update

18 / 11 / 2011

Viveve A Bronze Winner of the Clio Healthcare Design and Diagnostics Award

14 / 11 / 2011

SHC C Pulse Feasibility Trial Announcement ASX

07 / 11 / 2011

Sunshine Heart- Investor News Q3 2011

28 / 10 / 2011

Venture Capital in Australian Biotech- ABC transcipt

27 / 10 / 2011

Investment in Verva by the Medical Research Commercialisation Find (MRCF)

27 / 10 / 2011

Deakin diabetes hope

25 / 10 / 2011

Sunshine Heart�??s Feasibility Trial Outcomes to Be Presented at Transcatheter Cardiovascular Therapeutics Conference

20 / 10 / 2011

GBS Ventures completes healthcare fund with global first quartile performance

17 / 10 / 2011

Viveve sponsors study in Japan for new procedure to treat vaginal laxity

03 / 10 / 2011

RBS Morgans: Brave Heart- Sunshine Heart

26 / 09 / 2011

Displaying records 1-25 of 60